Irinotecan Liposome


  • Irinotecan, a camptothecin derivative, is a topoisomerase I inhibitor that inhibits cell growth and has broad-spectrum antitumor effects. This product is a PEGylated pre-formulated liposome with irinotecan. It is only for research purposes and for the injection to laboratory animals. Learn more about Irinotecan Liposome.



  • Research in this area could lead to new therapies with minimal side effects, which is of great benefit to patients. This is certainly an exciting prospect for future innovation in oncology.


Please login to reply this topic!